BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Oridonin

16,17-exo-epoxide-oridonin [Supplementary Concept] from Rabdosia rubescens; structure in first source Heading Mapped to: Diterpenes, Kaurane

300+ PubMed studies analyzed · Evidence Score: 37.9

Research Domains

Oridonin has been studied across 20 research domains including 🔬 Oncology, 🔬 Inflammation, 🫁 Liver & Detox, ⏳ Longevity & Aging, 🧘 Stress & Anxiety. The primary research focus is 🔬 Oncology with 57% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Oridonin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

curculigo
2 shared targets
gentiana
2 shared targets
anemarrhena
2 shared targets
alisma
2 shared targets
cnidium
2 shared targets
gastrodia
2 shared targets
lithospermum
2 shared targets
platycodon
2 shared targets
scolopendra
2 shared targets
aster
2 shared targets
Loading evidence profile...

This evidence profile for Oridonin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.